אתם נמצאים ב : LEM Lab > Staff > Management

Professor Ben-Hur Herzel


Herzl Ben-Hur, M.D.
CURRICULUM VITAE,
MAY 2007
 
Personal ID 06494506-6
Born: Iran, 1948; Married, 4 children.
1957               Immigration to Israel with family
1967               Graduated High School in Herzelia
1967- 1970    Compulsory military service. Present rank: Colonel
Medical studies
1970-1972     University of Sienna Medical School, Sienna, Italy
1973-1977     Sackler School of Medicine, Tel Aviv University, Tel- Aviv.
1977               Rotating Internship, Ichilov Hospital, Tel Aviv
1978-1984     Residency in Obstetrics and Gynecology, Kaplan Hospital, Rehovot (Affiliated to the Hebrew University Medical School)
1984               Board certification in obstetrics and gynecology
Advanced Training
1985               Postgraduate training in Gyneco-Oncological Surgery, Queen Elizabeth Hospital, Gateshead, Newcastle, England (Mr. J. M. Monaghan).
1987               Postgraduate training in General and Vascular Surgery, Kaplan Hospital, Rehovot (Chairmen: Prof. R. Pffeferman and Dr. A. Mashiah).
1987-1994     Several two months courses of training and refinement of surgical skills with Mr. Dr. J. M. Monaghan
1997               Residency course (30 d) in Advanced Gynecological Laparoscopic (Level 4) and Hysteroscopic (Level 3) Surgery. Mr Dr. J. H. Phipps, Nuneaton, UK.
Academic and Professional Responsibilities
1982               Instructor, Hebrew University School of Medicine
1982-1995     In charge of fifth year medical students clerkship in obstetrics and gynecology, in our department.
1986               Consultant, Obstetrics & Gynecology, Kaplan Hospital, Rehovot
1991 - 2001  Deputy Head, Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot Israel.
1993 - present      Visiting Scientist, Weizmann Institute of Science, Rehovot.
1997 - 2001   Senior Lecturer, School of Medicine, Hebrew University Jerusalem
1997- 2001    Mentoring and supervision of MD dissertations.
Kaplan Medical Center, Rehovot affiliated to the Hebrew University Jerusalem
1997- 2001    Mentoring and supervision of residents. Advanced training and research in Basic Sciences.
 
2001- present Senior Obstetrician, Gynecologist & Gyneco-Oncologist, General Health Services, Central District, Lod Center, Israel.
2001 - present      Senior Obstetrician, Gynecologist & Gyneco-Oncologist, Assaf Harofeh Medical Center.
2002 - present      Head, Laboratory for Experimental Medicine, and Early Detection, Weizmann Park, Rehovot, Israel.
 
 
Prizes and Awards
1982 Recipient of Rogozinsky Prize for outstanding work as Senior Registrar
1999 Selected by students in the Faculty of Medicine among the "Best Teachers" in the Hebrew University Medical School, Jerusalem.‏
Professional Society Memberships
1979               Israel Medical Association
1984               Israel Society of Obstetrics & Gynecology
1987               Israel Society of Gynecological Oncology
1988               Israel Society of Fertility & Sterility
l994                European Society of Gynaecologic Oncology
2000               Israel Society of Colposcopy and Cervical Pathology
Grants
1993-present From the Chief Scientist of the Israeli Ministry of Health, for Expression of Estrogen & Progesterone receptors in normal and pathological human veins.
 
LIST OF PUBLICATIONS,
MAY 2007
B1 ORIGINAL ARTICLES  
 
1.        Gilat T, Ben Hur H Gelman Malachi E, Terdiman R, Peled Y. 
Alterations of the colonic flora and their effect on the hydrogen breath test. 
Gut; 19(7), 602-5, 1978.
 
2.        Borenstein R, Apelman Z, Lancet M, Ben Hur H, Hegesh E, Chen M. 
The clinical significance of rheometric measurement of cervical mucus properties. 
Gynecol Obstet Invest; 14(1), 32-8, 1982.
 
 
3.        Katz Z, Lancet M, Dgani R, Ben Hur H, Zalel Y. 
The beneficial effect of vacuum extraction of the fetus. 
Acta Obstet Gynecol Scand; 61(4), 337-40, 1982. 
 
 
4.        Katz Z, Lancet M, Apelman Z, Ben Hur H. 
Ritodrine for uncoordinated uterine activity. 
Harefuah; 104(5), 168-70, 1983.
 
 
5.        Katz Z, Lancet M, Yemini M, Mogilner BM, Feigl A, Ben Hur H. 
Treatment of premature labor contractions with combined ritodrine and indomethacine. 
Int J Gynaecol Obstet; 21(4), 337-42, 1983.
 
 
6.        Katz Z, Yemini M, Lancet M, Mogilner BM, Ben Hur H, Caspi B. 
Non-aggressive management of post-date pregnancies. 
Eur J Obstet Gynecol Reprod Biol; 15(2), 71-9, 1983.
 
 
7.        Ben Hur H, Ornoy A. 
Ultrastructural studies of initial stages of mineralization of long bones and vertebrae in human fetuses. 
Acta Anat Basel; 119(1), 33-9, 1984.
 
 
8.        Czernobilsky B, Lifschitz Mercer B, Luzon A, Jacob N, Ben Hur H, Gorbacz S, Fogel M. 
Cytokeratin patterns in the epidermis of human ovarian mature cystic teratomas. 
Hum Pathol; 20(2), 185-92, 1989.
 
 
9.        Ben Hur H, Pecht M, Netzer L, Borenstein R, Blickstein I, Burstein Y, Trainin N. 
Immune modulation exerted by thymic humoral factor (THF-gamma 2) on T-cell subsets and IL-2 production of umbilical cord blood lymphocytes. 
Immunopharmacol Immunotoxicol; 12(1), 123-33, 1990.
 
 
10.    Abir R, Zusman I, Ben Hur H, Yaffe P, Ornoy A. 
The effects of serum from women with miscarriages on the in vitro development of mouse preimplantation embryos. 
Acta Obstet Gynecol Scand; 69(1), 27-33, 1990.
 
 
11.    Ben-Hur H, Blickstein I, Mavor I, Mor E Golan A. 
Spontaneous intestinal perforation during late pregnancy. 
Isr J Obstet Gynecol; 1 (2), 68-69, 1990.
 
 
12.    Bar Peled O, Gross Isseroff R, Ben Hur H, Hoskins I, Groner Y, Biegon A. 
Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors. 
Neurosci Lett; 127(2), 173-6, 1991.
 
 
13.    Caspi B, Elchalal U, Dgani R, Ben Hur H, Rozenman D, Nissim F. 
Invasive mole and placental site trophoblastic tumor: Two entities of gestational trophoblastic disease with a common ultrasonographic appearance. 
J Ultrasound Med; 10(9), 517-9, 1991.
 
 
14.    Bar Peled O, Israeli M, Ben Hur H, Hoskins I, Groner Y, Biegon A. 
Developmental pattern of muscarinic receptors in normal and Down's syndrome fetal brain--an autoradiographic study. 
Neurosci Lett; 133(2), 154-8, 1991.
 
 
15.    Blickstein I, Ben Hur H, Borenstein R. 
Perinatal outcome of twin pregnancies complicated with preeclampsia. 
Am J Perinatol; 9(4), 258-60, 1992.
 
 
16.    Elson Y, Bernstein H, Degani R, Ben-Hur H, Groner Y. 
Gene dosage and Down's syndrome: Metabolic and enzymatic changes in PC12 cells overexpressing transfected human liver-type phosphofructokinase. 
Somat Cell Mol Genet; l8(2), l43-161, 1992.
 
 
17.    Ornoy A, Abir R, Yaffe P, Ben Hur H, Pinus H. 
Correlation between yolk sac damage and embryonic anomalies induced by serum from women with recurrent abortions in early somite rat embryos in culture. 
Teratology; 45(5), l62, 502-503, l992, 1992.
 
 
18.    Borenstein R, Elchalal U, Goldchmit R, Rosenman D, Ben Hur H, Katz Z. 
The importance of the endopelvic fascia repair during vaginal hysterectomy. 
Surg Gynecol Obstet; 175(6), 551-4, 1992.
 
 
19.    Szmuk P, Ezri T, Ben Hur H, Caspi B, Priscu L, Priscu V. 
Regional anesthesia for circumcision in adults: a comparative study. 
Isr J Med Sci; 29, l28-l29, 1993.
 
 
20.    Abir R, Ornoy A, Ben Hur H, Yaffe P, Pinus H. 
IgG exchange as a mean of partial correction of malformations induced by recurrent abortions sera to rat embryos in vitro. 
Toxicol In Vitro; 7, 8l7-826, 1993.
 
 
21.    Ben Hur H, Mor G, Blickstein I, Likhman I, Kohen F, Dgani R, Insler V, Yaffe P, Ornoy A. 
Localization of estrogen receptors in long bones and vertebrae of human fetuses. 
Calcif Tissue Int; 53(2), 91-6, 1993.
 
 
22.    Mor G, Amir-Zaltsman Y, Barnard G, Ben Hur H, Kohen F. 
Evidence for the presence of estrogen receptors in monocytes. 
Endocr J; l, 387-395, 1993.
 
 
23.    Blickstein I, Weissman A, Ben Hur H, Borenstein R, Insler V. 
Vaginal delivery of breech-vertex twins. 
J Reprod Med; 38(11), 879-82, 1993.
 
 
24.    de Groot N, Goshen R, Rachmilewitz J, Gonik B, Ben Hur H, Hochberg A. 
Genomic imprinting and b-chorionic gonadotropin: comment. 
Prenat Diagn; 13(12), 1159-60, 1993.
 
 
25.    Gurevich P, Ben Hur H, Czernobilsky B, Nyska A, Zuckerman A, Zusman I. 
Pathology of lymphoid organs in low-birth-weight human fetuses subjected to antigen-induced influences: a morphological and morphometric study. 
Pediatr Pathol; 14(4), 679-93, 1994.
 
 
26.    Hahn T, Shulman LM, Ben Hur H, Karov Y, Barak V, Handgretinger R, Barak Y. 
Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor. 
Exp Hematol; 22(2), 114-21, 1994.
 
 
27.    Szmuk P, Ezri T, Ben Hur H, Caspi B, Priscu L, Priscu V. 
Regional anaesthesia for circumcision in adults: a comparative study. 
Can J Anaesth; 41(12), 1181-4, 1994.
 
 
28.    Yam D, Ben Hur H, Fink A, Dgani R, Shani A, Eliraz A, Insler V, Berry EM. 
Insulin and glucose status, tissue and plasma lipids in patients with tumours of the ovary or endometrium: possible dietary implications. 
Br J Cancer; 70(6), 1186-7, 1994.
 
 
29.    Abir R, Ornoy A, Ben Hur H, Jaffe P, Pinus H. 
The effects of sera from women with spontaneous abortions on the in vitro development of early somite stage rat embryos. 
Am J Reprod Immunol; 32(2), 73-81, 1994.
 
 
30.    Shezen E, Okon E, Ben Hur H, Abramsky O. 
Cytokeratin expression in human thymus: immunohistochemical mapping. 
Cell Tissue Res; 279(1), 221-31, 1995.
 
 
31.    Gurevich P, Czernobilsky B, Ben Hur H, Nyska A, Zuckerman A, Zusman I. 
Pathology of lymphoid organs in low birth weight infants subjected to antigen-related diseases: a morphological and morphometric study. 
Pathology; 27(2), 121-6, 1995.
 
 
32.    Ben Hur H, Mor G, Insler V, Blickstein I, Amir Zaltsman Y, Kohen F. 
Assessment of estrogen receptor distribution in human endometrium by direct immunofluorescence. 
Acta Obstet Gynecol Scand; 74(2), 97-102, 1995.
 
 
33.    Ben Hur H, Mor G, Insler V, Blickstein I, Amir Zaltsman Y, Sharp A, Globerson A, Kohen F. 
Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. 
Am J Reprod Immunol; 34(6), 363-9, 1995.
 
 
34.    Zusman I, Zusman R, Korol D, Sandler B, Ben Hur H, Bass D, Mashiah A, Mercer BL, Smirnoff P, Glick J. 
Isolation of p 53 protein from the serum of colon cancer and non-cancer patients. 
Oncology Reports; 2, 679-683, 1995.
 
 
35.    Yam D, Fink A, Mashia A, Ben Hur H. 
Hyperinsu1inemia in colon stomach and breast cancer patients. 
Cancer Lett; 104, 129-132, 1996.
 
 
36.    Gelman Kohan Z, Rosensaft J, Ben Hur H, Haber A, Chemke J. 
Cytogenetic analysis of fetal chondrocytes: a comparative study. 
Prenat Diagn; 16(2), 165-8, 1996.
 
 
37.    Yam D, Ben Hur H, Dgani R, Fink A, Shani A, Berry EM. 
Subcutaneous omentum and tumor fatty acid composition, and serum insulin status in patients with benign or cancerous ovarian or endometrial tumors: Do tumors preferentially utilize polyunsaturated fatty acids. 
Cancer Lett; 111(1-2), 179-85, 1997.
 
 
38.    Ben Hur H, Berman V, Sandler B, Smirnoff P, Gurevich P, Open M, Zusman I. 
Serological and immunohistochemical determinations of p53 protein in diagnosis of endometrial cancer: a comparative study. 
Eur J Gynaecol Oncol; 18(5), 400-6, 1997.
 
 
39.    Ben Hur H, Thole HH, Mashiah A, Insler V, Berman V, Shezen E, Elias D, Zuckerman A, Ornoy A. 
Estrogen, progesterone and testosterone receptors in human fetal cartilaginous tissue: immunohistochemical studies. 
Calcif Tissue Int; 60(6), 520-6, 1997.
 
 
40.    Ben Hur H, Gurevich P, Huszar M, Ziv Sokolovsky N, Zion H, Isaegson I, Berman V, Zusman I. 
Immunoglobulin A in the epithelium of the respiratory tract and intrahepatic bile ducts of fetuses and newborns with pneumonia and sepsis. 
Hum Antibodies; 8(3), 119-23, 1997.
 
 
41.    Bar Peled O, Ben Hur H, Biegon A, Groner Y, Dewhurst S, Furuta A, Rothstein JD. 
Distribution of glutamate transporter subtypes during human brain development. 
J Neurochem; 69(6), 2571-80, 1997.
 
 
42.    Dekel B, Burakova T, Ben Hur H, Marcus H, Oren R, Laufer J, Reisner Y. 
Engraftment of human kidney tissue in rat radiation chimera: II. Human fetal kidneys display reduced immunogenicity to adoptively transferred human peripheral blood mononuclear cells and exhibit rapid growth and development. 
Transplantation; 64(11), 1550-8, 1997.
 
 
43.    Tendler Y, Ben Hur H, Gurevich P, Berman V, Sandler B, Nyska A, Zion H, Zinder O, Zusman I. 
Role of apoptosis, proliferating cell nuclear antigen and p53 protein in the immune response of rat colon cells to cancer and vaccination with anti-p53 polyclonal antibodies. 
Anticancer Res; 17(6D), 4653-7, 1997.
 
 
44.    Ben Hur H, Gurevich P, Zion H, Berman V, Tendler Y, Sandler B, Zinder O, Zusman I. 
Immune response of rat spleen cells to a carcinogen and to vaccination with anti-p53 polyclonal antibodies. 
Anticancer Res; 18(1A), 273-82, 1998.
 
 
45.    Ben Hur H, Gurevich P, Hagay Z, Huszar M, Ziv-Sokolovskaya N, Shezen E, Zusman I. 
Insufficiency of the immune system in fetuses and infants with sepsis: Morphological and morphometric studies. 
J Histotechnol; 21, 1-7, 1998.
 
 
46.    Madar Z, Gurevich P, Ben Hur H, Ben Arie A, Berman V, Sandler B, Timar B, Tendler Y, Zinder O, Stark A, Zusman I. 
Effects of dietary fiber on the rat intestinal mucosa exposed to low doses of a carcinogen. 
Anticancer Res; 18(5A), 3521-6, 1998.
 
 
47.    Ben Hur H, Ben Meir A, Hagay Z, Ben Meir A, Berman V, Schwartsburd B, Gurevich P, Sandler B, Tendler Y, Zinder O, Zusman I. 
Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in mice. 
Anticancer Res; 18(6A), 4237-42, 1998.
 
 
48.    Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben Hur H, Many A, Shultz L, Lider O, Alon R, Zipori D, Lapidot T. 
Dependence of human stem cell engraftment and repopulation of NOD/ SCID mice on CXCR4. 
Science; 283(5403), 845-8, 1999.
 
 
49.    Zusman I, Gurevich P, Ben Hur H, Berman V, Sandler B, Tendler Y, Madar Z. 
The immune response of rat spleen to dietary fibers and to low doses of carcinogen: morphometric and immunohistochemical studies. 
Oncol Rep; 5(6), 1577-81, 1998.
 
 
50.    Mashiah A, Berman V, Thole HH, Rose SS, Pasik S, Schwarz H, Ben Hur H. 
Estrogen and progesterone receptors in normal and varicose saphenous veins. 
Cardiovasc Surg; 7(3), 327-31, 1999.
 
 
51.    Kollet O, Aviram R, Chebath J, Ben Hur H, Nagler A, Shultz L, Revel M, Lapidot T. 
The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+) CD38(-/low) cells capable of repopulating severe combined immunodeficiency mice. 
Blood; 1 94(3), 923-31, 1999.
 
 
52.    Ben Hur H, Plonsky E, Gurevich P, Berman V, Tendler Y, Moriel E, Guy M, Sandler B, Rozenberg V, Zusman R, Zusman I. 
Morphological and morphometric studies of the splenic antitumor immune response, elicited by liposome-covered soluble p53 kDa antigen, in chemically-induced rat colon cancer. 
Int J Mol Medicine; 3(5), 545-9, 1999.
 
 
53.    Ben Hur H, Dgani R, Ben Arie A, Open M, Shani A, Hagay Z. 
Diagnostic dilemmas and current therapy of Fallopian tube cancer. 
Eur J Gynaecol Oncol; 20(2), 108-9, 1999.
 
 
54.    Ben Hur H, Gurevich P, Huszar M, Ben-Arie A, Berman V, Tendler E, Tchanishev R, Zinder O, Mor G, Zaltsman Y, Kohen F, Zusman I. 
Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: immunohistochemical and morphometric studies. 
Eur J Gynec Oncol; 20 (4), 249-253, 1999.
 
 
55.    Ben Hur H, Plonsky E, Berman V, Tendler Y, Gurevich P, Moriel E, Guy M, Sandler B, Zusman I. 
Transplacental effects of IgG generated against soluble 53 kDa protein on the splenic lymph system of rat progeny exposed to carcinogen: rate of apoptosis, proliferation of lymphocytes and expression of Fas and Fas ligand proteins. 
Eur J Gynaecol Oncol; 20 (4), 306-310, 1999.
 
 
56.    Sandler B, Smirnoff P, Ben Hur H, Zusman R, Zusman I. 
An improved method for isolation and purification of soluble tumor-associated proteins from the serum of cancer patients. 
Exp Oncol; 21, 55-58, 1999.
 
 
57.    Gurevich P, Ben Hur H, Sandler B, Berman V, Tendler Y, Zinder O, Zusman I. 
Effects of low doses of carcinogen and different antibodies on the splenic lymphoid system of p53 transgenic mice: morphometric and immunohistochemical studies. 
Int J Mol Med; 4(2), 197-202, 1999.
 
 
58.    Peled A, Grabovsky V, Habler L, Sandbank J, Arenzana-Seisdedos F, Petit I, Ben Hur H, Lapidot T, Alon R. 
The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. 
J Clin Invest; 104 (9), 1199-1211, 1999.
 
 
59.    Globerson A, Kollet O, Abel L, Fajerman I, Ballin A, Nagler A, Slavin S, Ben Hur H, Hagay Z, Sharp A, Lapidot T. 
Differential effects of CD4+ and CD8+ cells on lymphocytes development from human cord blood cells in murine fetal thymus explants. 
Exp Hematol; 27, 282-292, 1999.
 
 
60.    Kollet O, Moor JG, Aviram R, Ben Hur H, Liu BL, Nagler A, Shultz L, Feldman M, Lapidot T. 
The plant lectin FRIL supports prolonged in vitro maintenance of quiescent human cord blood CD34+CD38-/1ow/SCID repopulating cells. 
Exp Hematol; 28(6), 726-736, 2000.
 
 
61.    Kohen F, Gayer B, Amir-Zaltzman Y, Ben-Hur H, Thomas E, Lu W, Lee-Jane A. 
Nonisotopic enzyme-based immunoassay for assessing human exposure to Genistein. 
Nutr Cancer; 35(1), 96-103, 1999.
 
 
62.    Tendler Y, Ben-Hur H, Gurevich P, Sandler B, Berman V, Zinder O, Zusman I. 
Response of the spleen of Balb/c and p53-Transgenic mice to low doses of carcinogen and to polyclonal antibodies generated against the soluble 53 kDa protein. 
Anticancer Res; 20, 385-390, 2000.
 
 
63.    Dekel B, Marcus H, Ben-Hur H, Bocher W, Reisner Y. 
In vivo modulation of the immune response by human fetal kidneys: The role of cytokines, chemokines, cytolytic effector molecules. 
Transplantation; 69, 1231-1241 , 2000.
 
 
64.    Ben-Hur H, Gurevich P, Huszar M, Ben-Arie A, Berman V, Tendler Y, Zinder O, Tchanishev R, Mor G, Zaltsman Y, Kohen F, Zusman I. 
Apoptosis and apoptosis related-proteins (Fas, Fas ligand, Bcl2 and P53) in lymphoid elements of human ovarian tumors. 
Eur J Gynecol Oncol; 21 (1), 53-57, 2000.
 
 
65.    Kollet O, Peled A, Byke T, Ben-Hur H, Shultz L, Lapidot T. 
b2-microglobulin deficient (B2mnull) NOD/SCID mice are excellent recipients for studying human stem cell function. 
Blood; 95(10), 3102-5, 2000.
 
 
66.    Ben-Hur H, Phipps JH. 
Laparoscopic hysterectomy: Possible reduction of ureteral injuries with ureteral transillumination: minimization of complications with uretral transillumination. 
J Am Assoc Gynecol Laparosc; 7 (1), 103-106, 2000.
 
 
67.    Ben-Hur H, Gurevich P, Ben-Arie A, Huszar M, Berman V, Tendler Y, Zinder O, Mor G, Tchanishev T, Gershon S, Zusman I. 
Apoptosis and apoptosis-related proteins in macrophages of human ovarian tumors: Morphometric and immunohistochemical studies. 
Eur J Gynec Oncol; 21, 141-145, 2000.
 
 
68.    Anisimov V.N, Popovich I.G, Shtylik A.V, Zabezhinski M.A, Ben-Hur H, Gurevich P, Berman V, Tendler Y, Zusman I. Melatonin and colon cancer. 
III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced 1,2-dimethylhydrazin in rats. 
Exp.Toxic. Pathol; 52, 71-76, 2000.
 
 
69.    Ben-Hur H, Kossoy G, Sandler B, Zusman I. 
Vaccination with soluble low-molecular weight tumour-associated proteins suppresses chemically-induced mammary tumorigenesis in rats. 
In vivo; 14, 551-554, 2000.
 
 
70.    Zusman I, Ben Hur H, Budovsky A, Geva D, Gurevich P, Tendker Y, Lavee S, Stark A, Madar Z. 
Transplacental effects of maternal feeding, with high fat diets on lipid exchange and response of the spleen lymphoid system in mice offspring exposed to low doses of carcinogen. 
Int J Molec Med; 6(3): 337-43, 2000.
 
 
71.    Kossoy G, Ben-Hur H, Popovich I, Zabezhinski M, Anisimov V, Zusman I. 
Melatonin and colon carcinogenesis. IV. Effect of melatonin on proliferative activity and expression of apoptosis-related proteins in the spleen of rats exposed to 1,2-dimethylhydrazine. 
Oncology reports.; 7, 1401-1405, 2000.
 
 
72.    Uni Z. Geyra A, Ben-Hur H, Sklan D. 
Small intestine development in the young chick: Crypt formation and enterocyte proliferation and migration. 
British Poultry science; 41, 544-551, 2000.
 
 
73.    Kossoy G, Yarden G, Ben Hur H, Bella S, Zusman I, Stark A, Madar Z. 
Transplacental effects of a 15% olive-oil diet on chemically-induced tumorigenesis in offsprings. 
Oncol Rep; 7, 1145-1148, 2000.
 
74.    Kossoy G, Yarden G., Ben-Hur H, Kossoy N., Stark A., Madar Z., Zusman I. 
Comparative effects of dimethylbenz (a) anthacene and a 15% olive-oil diet on cellular components and expression of apoptosis-related proteins in the spleen and mammary gland tumors in rats. 
Oncology reports; 8, 435-439, 2001.
 
 
75.    Ben-Hur H, Ashkenazi M, M. Huszar, Gurevich P, Zusman I. 
Lymphoid elements and apoptosis-related proteins (Fas, Fas ligand, p53 and bcl-2) in lichen sclerosus and carcinoma of the vulva in human. 
J Gynecol Oncol; 22, 104-109, 2001.
 
 
76.    Kossoy G, Ben-Hur H, Kossoy N, Zusman I. 
Effects of the soluble low-molecular-mass proteins on spleen activity and cellular composition of infiltrates in rat mammary gland tumors. 
Int J Molec Med; 7, 221-224, 2001.
 
 
77.    Gurevich P, Ben-Hur H, Berman V, Huszar M, Tendler Y, Zusman I. 
Expression of apoptosis and apoptosis-related proteins in microvessels of human ovarian epithelial tumors. 
Anticancer Res; 21, 1335-1338, 2001.
 
 
78.    Ben Hur H, Gurevich P, Calmanovich S, Gurevich E, Zusman I. 
Effect of giant hepatomaon lymphocyte production and secretion of apoptosis-related proteins in the rat spleen. 
Oncol Rep; 8, 731-735, 2001.
 
 
79.    Ben Hur H, Gurevich P, Calmanovich S, Gershon S, Zusman I. 
Tumor-induced insuffiency in T cell activity and hyperproduction of interleukin-2 in rat giant hepatomas. 
Int J Molec Med; 7, 269-272, 2001.
 
 
80.    Ben-Hur H, Kossoy G, Zusman I. 
Soluble low molecular-mass tumor-associated proteins promote the suppression of mammary tumors by cyclophosphamide. 
Int J Oncol; 19, 407-411, 2001.
 
81.    Kossoy G. Yarden G, Ben-Hur H, Kossoy Nadia, Stark A, Madar Z, Zusman I. 
Comparative effects of dimethylbenz(a)anthacene and a 15% olive-oil diet on cellular components and expression of apoptosis-related proteins in the spleen and mammary gland tumors of tats. 
Oncol Rep; 8, 435-439, 2001.
 
 
82.    Kossoy G. Yarden G, Madar Z, Ben-Hur H, Gal Rivka, Stark A, Choen O, Zusman I. 
Transplacental effect of a 15% olive-oil diet on functional activity of immune components in the spleen and colon tumors of rat offspring. 
Oncol Rep; 8, 1045-1049, 2001.
 
 
83.    Kossoy G, Ben-Hur H, Stark A, Zusman I, Madar Z. 
Effects of a 15% orange-pulp diet on tumorigenesis and immune response in rats with colon tumors. 
Oncology reports; 8, 1387-1391, 2001.
 
 
84.    Ben-Hur H, Gurevich P, Berman V, Tchanyshev R, Gurevich E, Zusman I. 
The secretory immune system as part of the placental barrier in the second trimester of pregnancy in humans. 
In Vivo; 15, 429-436, 2001.
 
 
85.    Gurevich P, Ben-Hur H, Moldavsky M, Szvalb S, Berman V, Zusman I. 
Immunoprotection of gonads and genital tracts in human embryos and fetuses: Immunohistochemical study. 
American journal of reproductive immunology.; 46, 381-385, 2001.
 
 
86.    Gurevich P, Ben-Hur H, Szvalb S, Moldavsky M, Zusman I. 
An immunohistochemical study of the secretory immune system in human fetal endocrine glands and their precursors. 
Early Pregnancy Pathol Med; 3, 191-200, 2001.
 
 
87.    Kossoy G. Yarden G, Ben-Hur H, Stark A, Madar Z, Zusman I. 
Effect of maternal feeding with different high fat diets on cellular composition of lymphoid compartments on the spleen and lymphoid infiltrates of mammary gland tumors in rat offspring. 
Exp Oncol; 23, 114-118, 2001.
 
 
88.    Gurevich P, Ben-Hur H, Szvalb S, Moldavsky M, Zuzman I. 
Lymphoid-Epithelial secretory immune system in human fetuses in the second trimester of gestation. 
Pediatric and developmental pathology; 5, 22-28, 2002.
 
 
89.    Ben-Hur H, Chohen O, Shcneider D, Gurevich P, Halperin R, Bala U, Mozes M, Zusman I. 
The role of lymphocytes and macrophages in human breast tumorigenesis: An immunohistological and morphometric study. 
Anticancer Res; 22, 1231-1238, 2002.
 
 
90.    Ben-Hur H, Kossoy G, Zandbank J. Zusman I. 
Response of the immune system of mammary tumor-bearing rats to cyclophosphamine and soluble low-molecular mass- tumor- associated antigens: Rate of lymphoid infiltration and distribution of T lymphocytes in tumors. 
Int J Molec Med; 9, 425-430, 2002.
 
 
91.    Ben-Hur H, Kossoy G, Zusman I. 
Soluble low-molecular-mass tumor-associated antigens prompt the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect. 
Int J Mol Med Oncol; 20, 413-7, 2002.
 
 
92.    Ben-Hur H, Kossoy G, Schneider DF, G, Zandbank J. Zusman I. 
Response of the immune system of mammary tumor-bearing rats to cyclophosphamine and soluble low-molecular mass- tumor- associated antigens, the spleen and lymph nodes. 
Int J Molec Med.; 9 (3), 311-6, 2002.
 
 
93.    Ben-Hur H, Kossoy G, Kossoy N, Zusman I. 
Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: The bone marrow and thymus. 
Int J Molec Med; 10, 517-521, 2002.
 
 
94.    Ben Hur H, Kossoy G. Yarden G, Kossoy Nadia, Zusman I. 
Effect of cyclophosphamide and soluble tumor-associated antigens on lyphoid infiltration, proliferative activity and rate of apoptosis in chemically-induced rat mammary tumors. 
In Vivo; 16, 287-292, 2002.
 
 
95.    Kossoy G. Stark A, Tendler Y, Ben-Hur H, Beniashvili D, Madar Z, Zusman I. 
Transplacental effect of high fat diets on functional activity of the spleen and lymph nodes, cell kinetics and apoptosis in mammary gland tumors in female rat offspring. 
Int J Molec Med; 10, 773-778, 2002.
 
 
96.    Ben-Hur H, Mordechay E, Reuvit H, Gurevitch P, Zandbank J, Meherdad H, Zusman I. 
Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors. 
Oncol Rep; 9, 977-980, 2002.
 
 
97.    Ben-Hur H, Kossoy G, Lifschitz O, Zusman I. 
Splenectomy, Chemically-induced mammary tumors and thymic lymph nodes in rats: Experimental and morphological studies. 
2002; 16, 275-280, In Vivo.
 
98.    Kossoy G, Ben Hur H, Lifschitz O, Zusman I. 
Mammary tumors in splenectomized rats. 
Oncology reports 9: 185-188, 2002.
 
99.    Gurevich P, Elhayany A, Ben-Hur H, Moldavsky M, Sergio S, Zandbank J, Schneider DF, Zusmann I. 
Secretory components, J chain and Immunoglobulins in human embryos and fetuses of the first trimester of pregnancy: an immunohistochemical study. 
Pediat Pathol; 6, 36-42, 2003.
 
 
100.Gurevich P, Elhayany A, Ben-Hur H, Moldavsky M, Sergio S, Zandbank J, Sperling I, Zusmann I. 
An immunohistochemical study of the secretory immune system in human fetal membranes and decidua of the first trimester pregnancy. 
Am J Reprod. Immunol; 50(1), 13-19, 2003.
 
 
101.Kossoy G, Zandbank J, Tendler E, Anisimov V, Khavinson V, Popovich I, Zabezhinski M, Zusman I, Ben-Hur H. 
Epitalin and colon carcinogenesis in rats: Proliferative activity and apoptosis in colon tumors and mucosa. 
Int J Molec Med; 12, 473-477, 2003.
 
 
102.Kossoy G, Ben Hur H, Avinoach I, Elhayany A, Shneider DF, Zuzmann I. 
Human soluble tumor- associated antigens promote the suppression of rat mammary tumors by 5-fluorouracil and stimulate the functional activity of immune organs: Experimental and morphological studies. 
Int J Molec Med; 12(5), 797-801, 2003.
 
 
103.Kossoy G, Avinoach I, Zuzmann I, Shneider DF, Ben Hur H, Elhayany A. 
Human soluble p66 and p51 tumor- associated antigens promote the suppression of rat mammary tumors in comparison to commercial human albumin. 
Oncol Rep; 11(2), 487-91, 2004.
 
 
104.Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S, Kollet O, Heshkovitz R, Alon R, Hardan I, Ben Hur H, Naor D, Nagler A, Lapidot T. 
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to the bone marrow. 
Blood; 103(8), 2981-9, 2004.
 
 
105.Ben Hur H, Kossoy G, Sanko H, Geva D, Shumlin N, Zuzmann I. 
Response of T- and B- lymphocytes in the spleen of mammary tumor- bearing rats to treatment with tamoxifen and soluble tumor-associated antigens. 
Oncol Rep; 12(1), 181-6, 2004.
 
 
106.Samira S, Ferrand C, Peled A, Nagler A, Tovbin Y, Ben Hur H, Tayl N, Globerson A, Lapidot T. 
Tumor necrosis factor promtes human T –cell development in nonobese diabetic/severe combined immunodeficient mice. 
Stem Cells; 22(6), 1085-100, 2004.
 
 
107.Ben Hur H, Kossoy G, Mehrdad H, Elhayany A, Zuzmann I. 
Response of T and B lymphocytes in the spleen, lymph nodes and mammary tumors in rats treated with human soluble tumor-associated antigens and commercial human albumin. 
Oncol Rep; 12(6), 1329-33, 2004.
 
 
108.Byk T, Kahn J, Kollet O, Petit I, Samira S, Shivtiel S, Ben-Hur H, Peled A, Piacibello W, Lapidot T. 
Cycling G1 CD34+/CD38+ cells potentiate the motility and engraftment of quiescent G0 CD34+/CD38-/low severe combined immunodeficiency repopulating cells. 
Stem Cells; 23(4), 561-74, 2005.
 
 
109.Kossoy G, Ben-Hur H, Elhayany A, Schneider DF, Zusman I. 
Rat soluble tumor-associated antigens inhibit chemically-induced mammary tumorigenesis in syngeneic rats. 
Oncol Rep; 13(4), 585-8, 2005.
 
 
110.Ben Hur H, Gurevich P, Elhayany A, Avinoach I, Schneider DF, Zuzmann I. 
Transport of maternal immunoglobulins through the human placental barrier in normal pregnancy and during inflammation. 
Int J Molec Med; 16(3), 401-7, 2005.
 
 
111.Kossoy G, Ben-Hur H, Elhayany A, Schneider DF, Kossoy N, Zusman I. 
Preventive effect of the soluble tumor-associated antigens on DMBA induced tumorigenesis in C3H/He mice oncology. 
Oncol Rep; 14(6), 1625-9, 2005.
 
 
112.Kossoy G, Ben-Hur H, Elhayany A, Schneider DF, Kossoy N, Zusman I. 
Effect of tamoxifen and soluble tumor-associated antigens on ovarian structure in mammary tumor-bearing rats. 
 
 
       Oncol Rep; 14(5), 1317-21, 2005.
 
 
113.Kossoy G, Ben-Hur H, Elhayany A, Schneider DF, Zusman I. 
The morphological pathway for mouse forestomach cancer. 
Oncol Rep; 15(2), 479-83, 2006.
 
 
114.Kossoy G, Anisimov VN. Ben-Hur H, Zusman I. 
Effect of synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice. 
In Vivo; 20(2), 253-7, 2006.
 
 
115.Kossoy G, Ben-Hur H, Miskin R, Zusman I. 
Tumor target organs and rate of survival in long-living transgenic mice and their parental wild-type counterparts exposed to the carcinogen dimethylbenz(a)anthracene.
In Vivo 20(4):543-8, 2006.
 
116. Spiegel A, Shivtel S, Kalinkovitch A, Ludin A, Netzer N, Goichberg P, Azaria Y, Resnick I, Hardan I, Ben Hur H, Nagler A, Rubinstein M, Lapidot T.
Catecolaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling.
       Nat Immunol. 8(10):123-31, 2007.
117. Gurevich P, Elhayany A, Milovanov AP, Halperin R, Kaganovsky E, Zusman I, Ben       
        Hur H.
        The placental barrier in allogenic immune conflict in spontaneousearly abortions:    
        immunohistochemical and morphological study.
        Am J Reprod Immuno. 58(5):460-7, 2007.
118. Halperin R, Elhayany A, Ben Hur H, Gurevich P, Kaganovsky E, Zusman I, Sinnar N, 
        Hadas E.
 Pathomorpholigic and immunohistochemical study on the devastation of rat embryos   
 by antiphospholipid andibody positive serum.
 Am J Reprod Immunol. 60(6):523-8, 2008.
 
 
Case reports (in peer reviewed journals only). 
 
1.        Katz Z, Ben Hur H. 
Death in-utero of one twin due to asymptomatic premature separation of the placenta. 
Harefuah; 107(9), 235-6, 1984.
 
2.        Ben Hur H, Dgani R, Lancet M, Katz Z, Nissim F, Rosenman D. 
Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. 
Acta Obstet Gynecol Scand; 65(7), 813-4, 1986.
 
 
3.        Dgani R, Blickstein I, Shoham Z, Czernobilsky B, Ben Hur H, Shani A, Katz Z, Borenstein R. 
Clinical aspects of ovarian tumors of low malignant potential. 
Eur J Obstet Gynecol Reprod Biol; 35(2 3), 251-8, 1990.
 
 
4.        Blickstein I, Feldberg E, Dgani R, Ben Hur H, Czernobilsky B. 
Dysplastic vulvar nevi. 
Obstet Gynecol; 78(5 Pt 2), 968-70, 1991.
 
 
5.        Zalel Y, Katz Z, Caspi B, Ben Hur H, Dgani R, Insler V. 
Spontaneous ovarian hyperstimulation syndrome concomitant with spontaneous pregnancy in a woman with polycystic ovary disease. 
Am J Obstet Gynecol; 167(1), 122-4, 1992.
 
 
6.        Blickstein I, Goldchmit R, Ben Hur H. 
Interrupted extra-ovular infusion may not be reversible. 
Adv Contracept; 8(4), 355-7, 1992.
 
 
7.        Shalev Y, Ben Hur H, Hagay Z, Blickstein I, Epstein M, Ayzenberg O, Gelven A, Caspi A. 
Successful delivery following myocardial ischemia during the second trimester of pregnancy. 
Clin Cardiol; 16(10), 754-6, 1993.
 
 
8.        Czernobilsky B, Gat A, Evron R, Dgani R, Ben Hur H, Lifschitz Mercer B. 
Carcinoma of the clitoris: a histologic study with cytokeratin profile. 
Int J Gynecol Pathol; 14(3), 274-8, 1995.
 
 
9.        Ben Hur H, Dgani R, Insler V, Lifschitz Mercer B, Blickstein I, Mor G, Kohen F, Shani A, Biran H. 
Hyperestrogenemia and presence of estrogen receptors associated with an epithelial ovarian tumor of low malignant potential. 
Eur J Gynaecol Oncol; 17(4), 260-3, 1996.
 
 
10.    Ben Hur H, Schachter M, Mashiah A, Lifschitz Mercer B, Pfeffermann R. 
Recurrent mucinous adenocarcinoma of the ovary presenting as an inguino-labial hernia. 
Eur J Gynaecol Oncol; 17(4), 299-302, 1996.
 
 
11.    Remadi S, Lifschitz Mercer B, Ben Hur H, Dgani R, Czernobilsky B. 
Metastasizing placental site trophoblastic tumor: immunohistochemical and DNA analysis: 2 case reports and a review of the literature. 
Arch Gynecol Obstet; 259(2), 97-103, 1997.
 
 
12.    Ben Arie A, Hagay Z, Ben Hur H, Open M, Dgani R. 
Elevated serum alkaline phosphatase may enable early diagnosis of ovarian cancer. 
Eur J Obstet Gynecol Reprod Biol; 86(1), 69-71, 1999.
 
 
13.    Ben Hur H, Zusman R, Zusman I. 
Autologous soluble tumor-associated antigens prevent the toxic side effects of cancer chemotherapy and inhibit the progress of tumorigenesis: Case report. 
Oncol Rep; 10(6), 2059-61, 2003.
 
 
Review Articles.
 
1.        Ben Hur H, Insler V. 
Relationship between cigarette smoking and epithelial cancer of the uterine cervix. 
Harefuah; 119(7-8), 221-3, 1990.
 
 
2.        Elson A, Weiss Y, Bernstein Y, Degani H, Levanon D, Ben-Hur H, Groner Y. 
Gene dosage effects of PFKL in transfected PC12 cells. 
Prog Clin Biol Res; 384, 135-56, 1993.
 
 
3.        Zusman I, Gurevich P, Gurevich E, Ben-Hur H. 
The Immune system, apoptosis and apoptosis related proteins in human ovarian tumors (A review). 
Int J Oncol; 18, 965-972, 2001.
 
 
4.        Zusman I, Ben-Hur H. 
Serological markers for detection of cancer: A review of current situation. 
Int J Molec Med; 7, 547-556, 2001.
 
 
5.        Ben-Arie A., Goldschmit R., Dgani R., Hazan Y., Ben-Hur H., Open M., Hagay Z. 
Trophoblastic peritoneal implants after laparoscopic treatment of ectopic pregnancy. 
Eur J Obstet Gynecol Reprod Biol,; 96, 113-115, 2001.
 
 
6.        Zusman I, Kossoy G. Ben-Hur H. 
Soluble low-molecular-mass heat shock proteins and tumor-associated antigens in prevention and therapy of chemically-induced cancers (Review). 
In Vivo; 15, 529-534, 2001.
 
 
7.        Zusman I, Kossoy G, Ben-Hur H. 
T cell kinetics and apoptosis in immune organs and mammary tumors of rats treated with cyclophosphamide and soluble tumor-associated antigens. 
In Vivo; 16, 567-576, 2002.
 
 
8.        Gurevich P, Zusmann I, Moldavsky M, Sergio S, Elhayany A, Reuvit H, Evgeny Gurevich, Sperling I, Ben-Hur H. 
Secretory immune system in human intrauterine development: Immunopathomorphological analysis of the role of secretory component (pIgR/SC) in immunoglobulin transport (Review). 
Int J Mol Med, 12, 289-297, 2003.
 
 
9.        Ben-Hur H, Gurevitch P, Elhayany A, Moldavsky M, Shvidel L, Shezen E. Shumlin N Zusman I. 
Secretory immune system in human embryonic and fetal development: Joining chain and immunoglobulin transport (Review). 
Int J Molec Med; 14(1), 35-42, 2004.
 
 
10.    Zusman I, Gurevich, Ben-Hur H. 
Tow secretory immune systems (mucosal and barrier)in human intrauterine development, normal and pathological (Review). 
Int J Molec Med; 16, 127-133, 2005.
 
 
Chapter in books. 
 
1.    Barak I, Karov Y, Levin S, Barash A, Ben-Hur H, Lancet M. 
Regulation of in vitro granulopoiesis by human fetal liver stromal cells. In: Fetal Liver Transplantation, Alan R (ed). Wiley-Liss. 
157-165, 1985.
 
 
2.    Elson A, Weiss Y, Bernstein Y, Degani H, Levanon D, Ben Hur H, Groner Y. 
Gene dosage effects of PFKL in transfected PCl2 cells. The Phenotypic Mapping of Down Syndrome and Other Aneuplid Conditions, Wiley-Liss. 
1993; 135-156.
 
 
 
 
Abstracts and Proceedings
1.    Graff G, Ben-Hur H, Lancet M. 
The use of B mimetics for suppression of uterine contractions. 
Joint Meeting of the American College of Obstetrics & Gynecology. Dist 1, Israel Society of Gyn Obet; Jerusalem, Tel-Aviv, 2-12 October 1979.
 
 
2.    Lancet M, Ben-Hur H, Graff G. 
Arrest of premature labour by ritodrine. 
The 9th International Congress of Obstet & Gynecol; Tokyo, Japan, 25-31 October, 1979.
 
 
3.    Katz Z, Lancet M, Appelman Z, Ben-Hur H. 
Mimetics for treatment of hypertonic uterine contractions and urgency states during labour. 
7th Scientific Meeting of the Israel Society of Obstetrics and Gynecology; Jerusalem, 1980.
 
 
4.    Katz Z Lancet M, Dgani R, Zalel J, Ben-Hur H. 
The effect of vacuum extraction on the fetus. 
7th Scientific Meeting of the Israel Society of Obstetrics and Gynecology; Jerusalem, 1980.
 
 
5.    Yemini M, Katz Z, Lancet M, Mogilner BM. Ben-Hur H. 
Non-aggressive management of post-date pregnancies. Uptake in high risk obstetrics. 
Israel Society of Obstetrics and Gynecology, in collaboration with the University of Southern California,; Jerusalem, 1981.
 
 
6.    Appelman Z, Katz Z, Lancet M, Ben-Hur H. 
A new approach to the treatment of uncoordinated uterine activity. 
Xth World Congress of Gynecology and Obstetrics; San Francisco, CA, 1982.
 
 
7.    Yemini M, Katz Z, Lancet M, Mogilner BM, Ben-Hur H. 
Conservative treatment of post-date pregnancies. 
Xth World Congress of Gynecology and Obstetrics; San Francisco, CA, 1982.
 
 
8.    Ornoy A, Ben-Hur H, Lancet M. 
Matrix vesicles and mineralization of cartilage in young human fetuses. 
XVII European Symposium on Calcified Tissues; Davos, Switzerland, 11-14 April 1983.
 
 
9.    Ben-Hur H, Ornoy A. 
Ultrastructural studies of the beginning of calcification of cartilage and bone in human embryos. 
Israel Association of the Study of Hard Tissue; Tel Aviv, Israel, March 16, 1983.
 
 
10.Ben-Hur H, Dgani R, Lancet M, Shani A, Nissim P, Czernobilsky B. 
Borderline epithelial ovarian tumor with unusual features. 
8th Congress of Israel Society of Obs & Gynec; Haifa, 1984.
 
 
11.Borenstein R, Lancet M, Finkelman M, Ben-David M, Ben-Hur H. 
Transient hyperprolactinemia as a cause of habitual abortions. 
8th Congress of Israel Society of Obst & Gynec; Haifa, 1984.
 
 
12.Ben-David M, Finkelman M, Ben-Hur H, Lancet M, Borenstein R. 
Receptors for ISO prolactin B in the human pseudodecidua. A possible cause for repeated abortions. 
8th Congress of Israel Society of Obst & Gynec; Haifa, 1984.
 
 
13.Abir R, Zusman I, Ben-Hur H, Yaffe P, Ornoy A. 
Effect of serum from women with recurrent abortions on in vitro development of mice blastocysts. 
1988; (Teratology 3813A), .
 
 
14.Friedman S, Ben-Hur H, Borenstein R, Burstein R, Trainin N. 
Thymic humoral factor THF- 2 enhances DNA repair in human lymphocytes. 
Isr J Med Sci; 1989, 25.
 
 
15.Pecht M, Lurie S, David M, Ben Hur H, Borenstein R, Burstein Y, Trainin N. 
Effect of THF-2 in vitro on phenotypic and functional expression in murine thymocytes and in human umbilical cord blood lymphocytes. 
Isr J Med Sci; 1989, 25.
 
 
16.Abir R, Ben-Hur H, Pinus H, Yaffe P, Ornoy A. 
The effects of sera from women with recurrent spontaneous abortions on the development of early somite rat embryos in vitro. 
Teratology Society Meeting; 1991, .
 
 
17.Dgani R, Piyura B, Blickstein I, Glaizerman M, Ben-Hur H, Yanay A, Czernobilsky B. 
Clinical aspects of Low Potential Malignant epithelial ovarian carcinoma. 
The 10th Congress of the Israel Society of Obstetrics and Gynecology; Jerusalem, December 19-20 1990.
 
 
18.Borenstein R, Elhalal A, Goldchmit G, Rosenman D, Ben-Hur H, Katz Z. 
Outcome of vaginal hysterectomy using Forge's technique with and without fascial suture . 
The 10th Congress of the Israel Society of Obstetrics and Gynecology; Jerusalem, December 19-20 1990.
 
 
19.Ornoy A, Abir R, Pinus N, Yaffe P, Ben Hur H, Zusman I. 
The use of embryo cultures to assess the embryotoxic and teratogenic effects of human serum. 
8th Israel Medical Week - 15th World Congress of the Israel, Medical Association; , Nov 6-8, 1991.
 
 
20.Ben Hur H, Mor G, Blickstein I, Dgani R, Insler V Kohen F. 
Immunocytochemical assessment of estrogen and progesterone receptor distribution in the human endometrium using anti-idiotypic antibodies. 
Annual Endocrinology Israel Association; Jerusalem, 1991.
 
 
21.Hahn T, Ben Hur H, Karov Y, Barak Y. 
Resistance of human fetal myelopoietic progenitor cell growth to inhibition by tumor necrosis factor and interferon. 
Advanced Concepts in Cancer Research; 2nd Israel Cancer Research Fund Scientific Conference p 74, 1991.
 
 
22.Abir R, Ben Hur H, Pinus H, Yaffe P, Ornoy A. 
The effects of sera from women with recurrent spontaneous abortion on the development of early somite rat embryos in vitro. 
European Developmental Biology Congress; Jerusalem Israel, August 11-16, 1991.
 
 
23.Ben Hur H, Mor G, Blickstein I, Likhman I, Amir- Zaltsman Y, Sharp A, Insler V, Globerson A, Kohen F. 
Expression of estrogen receptors (ER) in human peripheral blood is associated mainly with monocytes: A study during menopause. 
Annual Meeting of the Israel Endocrine Society; Tel Aviv, January 26-27, l993.
 
 
24.Abir R, Ornoy A, Pinus H, Ben Hur H, Jaffe P. 
Teratogenicity of sera from women with recurrent abortions is alleviated by IgG exchange. 
Annual Meeting of Israel Reproductive Immunology; Tel Aviv, March 3, l993.
 
 
25.Shezen E, Okon E, Ben Hur H, Abramsky O. 
Cytokeratin distribution in human thymus: immunohistochemical mapping. 
2nd International Congress ISNIM; Salerno, Italy, Sep l2-l7, l993.
 
 
26.Mor G, Amir-Zaltsman Y, Ben-Hur H, Sharp A, Kohen F. 
Expression of estrogen receptors in human peripheral blood mononuclear cells is associated mainly with monocytes. 
23rd Annual Meeting of the Israel Immunological Society; Beer Sheba, June l3-l4, l993.
 
 
27.Ben-Hur H, Mor G, Blickstein I, Likhman I, Amir-Zaltsman Y, Sharp A, Insler V, Globerson A, Kohen F. 
Expression of estrogen receptors (ER) in human monocytes in relation to menopause and hormone replacement therapy. 
23rd Annual Meeting of the Israel Immunological Society; Beer Sheba, June l3-l4, l993.
 
 
28.Ben-Hur H, Blickstein I, Likhman I, Sharp A, Insler V, Globerson A, Kohen F. 
Expression of estrogen receptors in human monocytes in relation to menopause and hormone replacement therapy. 
Israel Endocrine Society; Jerusalem, 19th October, l993.
 
 
29.Yam D, Ben-Hur H, Fink A, Eliraz A, Blickstein I, Chen M, Rozenberg M, Lupo M, Insler V. 
Role of insulin in women with uterine and ovarian malignancies, possible dietary implications. 
Israel Endocrine Society; Jerusalem, 20th October, l993.
 
 
30.Ornoy A, Abir R, Ben Hur H, Jaffe P, Pinus H. 
Yolk sac damage as a possible mechanism in IgG induced teratogenesis in cultured rat embryos. 
21st European Teratology Society Conference; Lyon, France, l993.
 
 
31.Ornoy a, Kimyagarov d, Jaffe p, Raz I, Ben Hur H, Abir R. 
The effect of sera from pregnant diabetic women on the in-vitro development of two-four cell stage mouse embryos. 
21st European Teratology Society Conference; Lyon, France, l993.
 
 
32.Ben Hur H, Schachter M, Pfeffermann R, Lifschitz-Mercer B, Dgani R. 
Recurrent mucinous adenocarcinoma of the ovary presenting as an inguino-labial hernia. 
First Israeli-French-Italian Gynecological Conference; Eilat, Israel, l994.
 
 
33.Ben Hur H, Insler V, Fink A, Dgani R, Yam D. 
Role of insulin in women with uterine and ovarian malignancies. Possible dietary implications. 
First Israeli-French-Italian Gynecological Conference; Eilat, Israel, l994.
 
 
34.Pecht M, Ben Hur H, Lourie S, Trainin N, Burstein Y. 
The thymic humoral factor (THF-2) selectively affects lymphokine production in vitro by human umbilical cord blood lymphocytes. 
6th International Congress of Immunopharmacology; Prague, June l994.
 
 
35.Ben Hur H, Yam D. 
Hyperinsulinemia - A common feature in certain tumor bearing patients. 
Israel Endocrine Society; Tel Aviv, December 1994.
 
 
36.Zusman, I, Zusman, R, Korol D, Sandler B, Ben-Hur H, Bass D, Or A, Glick J. 
Gel Fiberglass-A new Affinity Membrane for Isolation of Proteins. 
The First Meeting of FISEB; Eilat, Israel p. 43, 1995.
 
 
37.Zusman I, Zusman R, Korol D, Sandler B, Bass D, Ben-Hur H, Mashiah A, Lifschitz-Mercer B, Smirnoff P, Glick J. 
A method for isolation of p53 protein from blood of colon cancer and non cancer patients and its clinical application. 
The 1st world congress on advances in oncology (Int J Oncol); Athens, Greece, 1995.
 
 
38.Kollet O, Moor J, Fajerman I, Ben-Hur H, Hagay Z, Nagler A, Feidman A, Lapidot T. 
Prolonged in vitro maintenance of quiescent human CD34+/CD38- interlacing lectin (EFRIL). 
Hematol 39th Annual Meeting (J Am Soc, 90:1627); San Diego, CA, December 5-9 1997.
 
 
39.Kohen F, Lichter S, Gyer B, Amir-Zaltsman Y, Ben-Hur H, Lu LJW. 
Monoclonal antibodies to the isoflavones daidzein and genistein: probes for assessment of dietary soya exposure. 
Israel Endocrine Soc; , Dec 1997.
 
 
40.Zusman I, Ben-Hur H, Tendler Y, SandIer D, Berman V, Gurevich P, Zinder O, Shezen E. 
The role of apoptosis, dendritic cells, lymphocytes, proliferating cell index and p53 protein in the immune response of rats to carcinogenesis and vaccination. 
Apoptosis (Anticancer Res, 1997, 17: 3995-4024); Athens, Greece, 2-5 October 1997
 
 
41.Kollet O, Moor J, Fajerman I, Ben Hur H, Hagay Z, Nagler A, Feldman M Lapidot T. 
Prolonged in vitro maintenance of quiescent human CD34+/CD38 from cord blood by FLT-3 receptor interacting lectin (FRIL). 
Blood J Thirty-Ninth Annual Meeting Am Soc Hematol (Blood J Am Soc Hematol 90:10,1,446-III); San Diego, CA, December 5-9 1997 .
 
 
42.Ben-Hur H, Hagay Z, Open M, SandIer B, Berman V, Gurevich P, Smirnoff P, Tendler Y, Shezen E, Zusman I. 
Serological and immunohistochemical determination of p53 protein, in diagnosis of endometrial cancer: A comparative study. 
Israel Gynecological Oncology Society Congress pp. 44; Herzliya Israel, 1-2 January 1998.
 
 
43.Ben-Hur H, Hagay Z, Sandler B, Smirnoff P, Zusman I. 
The role of histochemical and serological determination of the soluble p53 protein in diagnosis of uterine cancer: . 
Fifty years of the science and practice of gynecological oncology; Queen Elizabeth Hospital, Gateshead UK, 11-15 May l998.
 
 
44.Zusman I, Sandler B, Smirnoff P, Ben-Hur H, Shani A, Gutman H. 
HPLC in cancer detection: from laboratory studies to clinical application. 
; 1998, .
 
 
45.Zusman I, Ben-Hur H, Tendler T, Sandler D, Berman V, Gurevich P. 
The role of the soluble antibodies in prevention of chemically induced cancers. 
Proceedings of the Sixth International Conference of Anticancer Research (Anticancer Res 18 (6C):4980, 1998); Greece, October 21-25 1998.
 
 
46.Zusman I, Ben-Hur H, Sandler D, Smirnoff P, Berman V, Gurevich P. 
The soluble p53 antigen as a marker for early detection of cancer. 
Proceedings of the Sixth International Conference of Anticancer Research; Greece (Anticancer Res 18 (6C):4981, 1998), October 21-25 1998).
 
 
47.Zusman I, Gurevich P, Tendler T, Berman V, Ben-Hur H, Sandler D, Zinder O, Hagay Z. 
The role of the immune system in the host’s response to a carcinogen and vaccination with anti-p53 antibodies. 
Presented at the 3rd World Congress on Advances in Oncology and the 1st International Symposium on Molecular Medicine (Int J Molec Med 2 (Sup 1):S9, 1998); Crete, Greece, Oct 15-17, 1998 (Int J Molec Med 2 (Sup 1):S9, 1998).
 
 
48.Ben-Hur H, Berman V, Hagay Z, Huszar M, Gurevich P, Zusman I, Mor G, Zalttsman Y, Kohen F. 
Development of human ovarian cancer: the role of FAS ligand and lymphoid infiltrates. 
Israel Endocrine Society A38; Tel- Aviv, January 25-28, 1999.
 
 
49.Zusman I, Ben-Hur H, Gurevich P, Berman V, Ben-Arie A, Huszar M, Tchanishev R, Tendler Y, Zinder O, Mor G, Zaltsman Y, Kohen F. 
Apoptosis and related proteins (Fas, FasL, bcl-2, p53) in human ovarian tumor. 
The 4th world congress on advances in oncology, 2nd International symposium on molecular medicine (Int J Mol Med 4: 1, 197, 1999); Vouliagmeni, Athens, Greece, 7-9 October, 1999 .
 
 
50.Kollet O, Moore J, Fajerman I, Ben Hur H, Hagay Z, Nagler A, Feldman M, Lapidot T. 
Prolonged in vitro maintenance of quiescent human CD34(+)/CD38(-) stem cells from cord blood by FLT-3 receptor interacting lectin (FRIL). 
Blood; 90 (10), 1627, 1999.
 
 
51.Zusman I, Ben-Hur H, Berman V, Sandler B, Plonsky E, Gurevich P, Smirnoff P, Tendler Y, Zinder O, Moriel E, Gay M. 
Transplacental effects of IgG generated against soluble 53 kDa protein on mammary tumorigenesis and the splenic of rat progeny exposed to carcinogen. 
The 4th world congress on advances in oncology, 2nd International symposium on molecular medicine (Int J Mol Med 4: 1, 198, 1999); Vouliagmeni, Athens, Greece, 7-9 October, 1999.
 
 
52.Kohen F, Bernard G, Ben-Hur H, Gayer B, Somjen D, Zallthsman Y. 
Estrogen mimetics: anti-idiotypes and phytoestrogens as probes for estrogen action. 
Life Sciences 2000 Open day, The Weizmann Institute of Science (pp 48-9); Rehovot, Israel, January 4, 2000.
 
 
53.Ben Hur H, Phipps JH. 
Laparoscopic hysterectomy: Possible reduction of ureteral injuries with ureteral transillumination. 
World Congress on Gynecological Endoscopy and the 1st annual meeting of the Israel Society of Gynecological Endoscopy (pp 59); Tel-Aviv, Israel, March 2000 .
 
 
54.Yoles I, Hyman E, Sadovsky G, Ben-Hur H. 
Is there a correlation between cervical appearance and PAP smear findings?. 
Fourth International Multidisciplinary Congress ( pp 129); Paris, France, April 5-9, 2000 .
 
 
55.Zusman I, Ben-Hur H, Gurevich P, Berman V, Tendler Y, Zinder O, Huszar M, Tchanishev R, Ben-Arie A, Mor G, Zaltsman Y, Kohen. 
Apoptosis and apoptosis related-proteins in tumorigenesis. A new approach to an old problem. 
5th World congress on advances in oncology and 3rd international symposium on molecular medicine; Crete, Greece, October 19-21, 2000.
 
 
56.Madar Z, Ben-Hur H, Stark AH, Budovsky A, Geva D, Lavee S, Gurevitch S, Zusman I. 
Maternal feeding of high fat diets modifies the splenic lymphoid system of mice offspring exposed to low doses of carcinogen. 
The 5th world congress on advances in oncology, and 3rd international symposium on molecular medicine (Int J Mol Med 2000; 6 (Supp 1)); Hersonissos, Crete, Greece, 19-21 October, 2000.
 
 
57.Zusman I, Kossoy G, Ben Hur H. 
Role of soluble tumor-associated antigens and their IgG in prevention and suppression of chemically-induced cancers (Anticancer Res 2001, 21: 1577- 1622). 
International Conference on New Anti-Cancer Agents; Athens, Greece, 9 – 12 June, 2001 .
 
 
58.Zusman I, Kossoy G, Ben Hur H. 
The role of the soluble low-molecular mass tumor- associated antigens in prevention and suppression of chemically-induced cancers. 
The 6th world congress on advances in oncology and 4th symposium on molecular medicine (Int J Mol Med 2001, 8: 141); Hersonissos, Crete, Greece, October 19-21, 2000.
 
 
59.Zusman I, Ben-Hur H, Kossoy G. 
Role of soluble tumor-associated antigens in prevention of toxic side-effects of tamoxifen and cyclophosphamide in mammary gland tumorigenesis. 
The 7th world congress on advances in oncology, 5th international symposium on molecular medicine; Hersonissos, Crete, Greece, October 19-21, 2000 (Int J Mol Med Oncol 2002; 10: Supplement 1, 123).